Blennow K - Search Results

1

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.

Timmers M, Tesseur I, Bogert J, Zetterberg H, Blennow K, Börjesson-Hanson A, Baquero M, Boada M, Randolph C, Tritsmans L, Van Nueten L, Engelborghs S, Streffer JR. Timmers M, et al. Among authors: blennow k. Neurobiol Aging. 2019 Jul;79:131-141. doi: 10.1016/j.neurobiolaging.2019.03.016. Epub 2019 Apr 1. Neurobiol Aging. 2019. PMID: 31055223

2

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. Aging (Milano). 1992 Dec;4(4):301-6. Aging (Milano). 1992. PMID: 1294245

3

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Blennow K, et al. Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850

4

Confusional symptomatology distinguishes early- and late-onset Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG. Blennow K, et al. Aging (Milano). 1990 Dec;2(4):395-401. Aging (Milano). 1990. PMID: 2094379

5

Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease.

Blennow K, Wallin A, Fredman P, Gottfries CG, Karlsson I, Svennerholm L. Blennow K, et al. Eur Neuropsychopharmacol. 1990 Nov;1(1):79-81. doi: 10.1016/0924-977x(90)90017-5. Eur Neuropsychopharmacol. 1990. PMID: 2136219

6

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.

Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blennow K, et al. Acta Neurol Scand. 1990 Apr;81(4):323-6. doi: 10.1111/j.1600-0404.1990.tb01563.x. Acta Neurol Scand. 1990. PMID: 2360400

7

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

8

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

9

Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease.

Karlsson JO, Blennow K, Janson I, Blomgren K, Karlsson I, Regland B, Wallin A, Gottfries CG. Karlsson JO, et al. Among authors: blennow k. Neurobiol Aging. 1995 Nov-Dec;16(6):901-6. doi: 10.1016/0197-4580(95)02004-7. Neurobiol Aging. 1995. PMID: 8622780

10

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Blennow K, et al. Mol Chem Neuropathol. 1995 Dec;26(3):231-45. doi: 10.1007/BF02815140. Mol Chem Neuropathol. 1995. PMID: 8748926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,222 results

Search Page

Filters